CS389891A3 - Diazabicyclo-(3,3,1)-nonanes - Google Patents

Diazabicyclo-(3,3,1)-nonanes

Info

Publication number
CS389891A3
CS389891A3 CS913898A CS389891A CS389891A3 CS 389891 A3 CS389891 A3 CS 389891A3 CS 913898 A CS913898 A CS 913898A CS 389891 A CS389891 A CS 389891A CS 389891 A3 CS389891 A3 CS 389891A3
Authority
CS
Czechoslovakia
Prior art keywords
nonanes
diazabicyclo
substituents
compounds
employed
Prior art date
Application number
CS913898A
Other languages
Czech (cs)
English (en)
Inventor
Uwe Dr Schon
Bernd Dr Hachmeister
Wolfgang Dr Kehrbach
Ulrich Dr Kuhl
Gerd Dr Buschmann
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of CS389891A3 publication Critical patent/CS389891A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CS913898A 1982-09-18 1991-12-19 Diazabicyclo-(3,3,1)-nonanes CS389891A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane

Publications (1)

Publication Number Publication Date
CS389891A3 true CS389891A3 (en) 1992-07-15

Family

ID=6173602

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913898A CS389891A3 (en) 1982-09-18 1991-12-19 Diazabicyclo-(3,3,1)-nonanes

Country Status (25)

Country Link
US (2) US4550112A (es)
EP (2) EP0103833B1 (es)
JP (2) JPS5970686A (es)
AT (2) ATE69817T1 (es)
AU (1) AU564910B2 (es)
CA (1) CA1254209A (es)
CS (1) CS389891A3 (es)
DD (1) DD213923A5 (es)
DE (3) DE3234697A1 (es)
DK (1) DK165833C (es)
ES (1) ES525653A0 (es)
FI (1) FI76338C (es)
GE (1) GEP19960316B (es)
GR (1) GR78722B (es)
HU (1) HU191096B (es)
IE (1) IE57580B1 (es)
IL (1) IL69751A (es)
MX (1) MX9202996A (es)
NO (1) NO160516C (es)
NZ (1) NZ205627A (es)
PH (1) PH20768A (es)
PT (1) PT77344B (es)
SU (1) SU1272989A3 (es)
UA (1) UA817A1 (es)
ZA (1) ZA836185B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
MXPA06000796A (es) * 2003-07-21 2006-04-07 Solvay Pharm Gmbh Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones.
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
WO2006135316A1 (en) * 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
LU76173A1 (es) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Also Published As

Publication number Publication date
FI76338C (fi) 1988-10-10
DE3380409D1 (de) 1989-09-21
ZA836185B (en) 1984-04-25
IE832186L (en) 1984-03-18
HU191096B (en) 1987-01-28
DE3234697A1 (de) 1984-03-22
EP0103833A3 (en) 1984-11-28
DK165833B (da) 1993-01-25
FI76338B (fi) 1988-06-30
IL69751A (en) 1986-10-31
NO160516B (no) 1989-01-16
AU1920683A (en) 1984-03-22
EP0103833A2 (de) 1984-03-28
AU564910B2 (en) 1987-09-03
SU1272989A3 (ru) 1986-11-23
US4550112A (en) 1985-10-29
ES8405398A1 (es) 1984-06-01
IL69751A0 (en) 1983-12-30
EP0250903B1 (de) 1991-11-27
DD213923A5 (de) 1984-09-26
PT77344B (en) 1986-03-11
DK165833C (da) 1993-06-21
ES525653A0 (es) 1984-06-01
CA1254209A (en) 1989-05-16
DK422583D0 (da) 1983-09-16
JPH0670056B2 (ja) 1994-09-07
JPS5970686A (ja) 1984-04-21
MX9202996A (es) 1992-07-01
GEP19960316B (en) 1996-06-24
EP0250903A3 (en) 1988-03-09
ATE45579T1 (de) 1989-09-15
FI833339A0 (fi) 1983-09-19
JPH05247039A (ja) 1993-09-24
NO833346L (no) 1984-03-19
PT77344A (en) 1983-10-01
GR78722B (es) 1984-10-02
NO160516C (no) 1989-04-26
ATE69817T1 (de) 1991-12-15
DE3382466D1 (de) 1992-01-09
PH20768A (en) 1987-04-10
EP0103833B1 (de) 1989-08-16
FI833339A (fi) 1984-03-19
NZ205627A (en) 1985-11-08
UA817A1 (uk) 1993-12-15
IE57580B1 (en) 1993-01-13
US4742172A (en) 1988-05-03
CA1259998C (es) 1989-09-26
EP0250903A2 (de) 1988-01-07
DK422583A (da) 1984-03-19

Similar Documents

Publication Publication Date Title
CS389891A3 (en) Diazabicyclo-(3,3,1)-nonanes
IL76454A0 (en) Diarylacetylenes,their preparation and pharmaceutical compositions containing them
ZA857270B (en) Tetralin derivatives,their preparation and their use
ES8105053A1 (es) Procedimiento para la preparacion de mezclas de aclaradores opticos
DE3561815D1 (en) 3-aminocarbonylmethoxy-5-phenylpyrazole compounds, process for their preparation and pharmaceutical compositions containing them
GR3003656T3 (es)
ZA876542B (en) Novel 3-methylphtalimides
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
GR77848B (es)
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
ZA86543B (en) 2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as therapeutics
IL99782A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them
ES8407047A1 (es) Un procedimiento para la preparacion de un compuesto de 5-aril-1,2,3,4-tetrahidro-y-carbolina-2-sustituida.